Polaryx Therapeutics (PLYX) Current Assets (2024 - 2026)
Polaryx Therapeutics (PLYX) posted quarterly Current Assets of $3.5 million for Q1 2026, down 32.26% quarter-over-quarter from $5.2 million in Q4 2025.
Polaryx Therapeutics (PLYX) Current Assets (2024 - 2026) Analysis & Trends
Polaryx Therapeutics (PLYX) has reported Current Assets for 3 consecutive years, with $3.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets changed N/A year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $3.5 million (changed N/A YoY), while the FY2025 annual figure was $5.2 million, up 3.38% from the prior year.
- Current Assets retreated to $3.5 million in Q1 2026 per PLYX's latest filing, from $5.2 million in the prior quarter.
- Across five years, Current Assets topped out at $5.2 million in Q4 2025 and bottomed at $3.5 million in Q1 2026.
- Historically, Current Assets has averaged $4.6 million across 3 years, with a median of $5.0 million in 2024.
- On a YoY basis, Current Assets climbed as much as 3.38% in 2025 and fell as far as 3.38% in 2025.
- Polaryx Therapeutics' Current Assets stood at $5.0 million in 2024, then advanced by 3.38% to $5.2 million in 2025, then sank by 32.26% to $3.5 million in 2026.
- Business Quant data shows PLYX's Current Assets at $3.5 million in Q1 2026, $5.2 million in Q4 2025, and $5.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Polaryx Therapeutics | 102.35 Mn | 90.81 Mn | - | 11.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.81 Mn |
| Mar 31, 2026 | 3.50 Mn |
| Dec 31, 2025 | 5.17 Mn |
| Dec 31, 2024 | 5.00 Mn |